Magnesium for Period Pain: What the Cochrane Evidence Actually Says

A widely shared claim calls magnesium a validated, risk-free fix for period pain, but the key Cochrane review (2016, 27 trials, 3,101 women) found only low-quality evidence and flagged safety gaps.

What the claims rest on

Product or subjectClaimEvidenceChecked
First-line treatment for primary dysmenorrheaNSAIDs remain first-line treatment for primary dysmenorrhea, with magnesium at most an adjunct.French clinical references from Vidal and the Belgian CBIP still list NSAIDs as first-line treatment.

A Doctissimo article by gynecologist Odile Bagot calls magnesium a "validated, risk-free" fix for period pain. The label overstates what the research actually shows.

The current reference review is Pattanittum et al., published in the Cochrane Database of Systematic Reviews in 2016 ("Dietary supplements for dysmenorrhoea"), covering 27 trials and 3,101 women. It found low-quality evidence that some supplements, magnesium among them, ease menstrual pain, and no high-quality evidence for any of them. An older 2001 Cochrane review by Proctor and Murphy, built on three small trials, first floated the magnesium benefit; Cochrane now labels that review outdated.

Two German trials from 1989 and 1990 supply most of the primary data behind the claim. A 2024 meta-analysis in BMC Women's Health, by Li and colleagues, reports a dose-dependent effect starting around 250 to 300 mg a day, a more recent signal worth weighing against the thinner older trials. A trial registered on ClinicalTrials.gov (NCT07248540) is now testing intravenous magnesium for acute dysmenorrhea in Turkey, which shows the question is still open.

The safety side needs the same scrutiny. Magnesium supplements are contraindicated in renal insufficiency, since the kidneys are the only clearance route. Loose stools commonly appear around 360 mg a day, and EFSA-style guidance puts the adult supplementation ceiling near 250 mg a day. Magnesium also cuts the absorption of tetracycline and nitrofurantoin antibiotics, some diuretics, bisphosphonates, and Parkinson's drugs.

French clinical references from Vidal and the Belgian CBIP still list NSAIDs as first-line treatment for primary dysmenorrhea, with magnesium at most an adjunct. Pain that resists NSAIDs is a recognized red flag for endometriosis, and guidance referenced by HAS and the CNGOF points to a pelvic ultrasound at that stage rather than another supplement.

The ongoing Turkish trial is testing magnesium by infusion, not by capsule, a reminder that the dose and form behind any future answer could look nothing like the tablets sold over the counter today.

Simon AdeyemiHealth and industry desk

Reports on health and wellness claims bordering beauty, and on the manufacturers, retailers, and regulators whose filings and enforcement actions shape what reaches shelves. Every claim carries its evidence grade and the conditions under which it was actually studied.

  1. Five vitamin D self-test kits, one blood sample, four different verdicts
  2. Sleep Under Six Hours and Lose Less Fat? What the Evidence Actually Shows
  3. Vitamin D Overdose Risk: What Anses Actually Found About Stacking Supplements and Hypercalcemia
  4. The "Light a Candle When You Get Home" Trend: What the Science Actually Shows